While low serum adiponectin levels have been associated with central obesity, insulin resistance, metabolic syndrome, and type 2 diabetes, ADIPOQ (rs16861209) has been significantly associated with elevated fasting serum adiponectin levels [37,38]. The gene discussed is ADIPOQ; the disease is Abdominal obesity.